A nurse is caring for an older adult client who has dementia. The client's family member asks why the provider will not prescribe a medication to calm the client down. Which of the following statements should the nurse make.

Choice A rationale While physical instability is a concern in dementia, the primary legal and clinical reason for avoiding traditional antipsychotics or sedatives in this population is the specific black box warning regarding cardiovascular and cerebrovascular events. Sedation can lead to gait disturbances, but the clinical priority for the provider is avoiding the life-threatening complications of strokes and increased mortality rather than the musculoskeletal risk of falling alone. Choice B rationale The use of atypical antipsychotics in older adults with dementia is associated with a significantly increased risk of cerebrovascular accidents, commonly known as strokes. The Food and Drug Administration has issued black box warnings for these medications because they also increase the mortality rate in elderly patients with dementia-related psychosis. The nurse must explain that these medications pose a severe risk to the client's neurological health and safety. Choice C rationale Medications used for calming or sedation do not typically have a direct physiological pathway that suppresses the immune system to a degree that significantly increases infection risk. While poor mobility from sedation might lead to secondary issues like stasis pneumonia, it is not the primary scientific reason providers avoid these drugs. The specific cardiovascular risks far outweigh the minor secondary risk of potential infection in these pharmacological contraindications. Choice D rationale Many medications used to calm patients, such as benzodiazepines or certain antipsychotics, are more likely to cause orthostatic hypotension rather than hypertension. A drop in blood pressure when standing increases the risk of syncope. Because the provider's concern is focused on the higher mortality rate from strokes and sudden cardiac death, stating that the drug increases blood pressure would be scientifically inaccurate in this clinical context.